Medical isotopes maker Shine Medical Technologies last week created a division to make therapeutic products, saying it plans to first focus on a cancer treatment. The Janesville, Wis.-based company said its Shine Therapeutics business will begin with the development and commercialization of lutetium-177, an isotope that can be combined with a disease-targeting molecule, for treating […]
Isotope maker Shine Medical raises $50m from Oaktree Capital
Shine Medical Technologies said this week that it closed a $50 million financing round from Oaktree Capital Management for the construction of a medical isotope production facility and commercialization of its products. The Janesville, Wis.-based company expects construction on the plant to be completed in 2021, with commercial-scale isotope production slated to begin the following […]
Innoblative taps ex-Lumicell chief Londy for CEO | Personnel Moves, Sept. 13, 2019
Innoblative Designs last week named former Lumicell chief executive Kelly Londy as its new CEO. Apart from her two-year stint at the Lumicell helm, Londy was COO at Accuray (NSDQ:ARAY) and worked at GE Healthcare and Philips Healthcare. “Innoblative’s Sira RF ablation device offers unique capabilities that address shortcomings in the current advanced energy surgical market,” […]
Shine Medical adds $18m
Shine Medical Technologies said last week that it raised another $18 million for the medical radioisotopes it makes. Janesville, Wis.-based Shine Medical said the equity, options and warrants round logged its first sale April 26 and has a total goal of $30 million. Some 99 unnamed investors participated in the $18.1 million round, according to […]
U of Missouri becomes first to ship isotope for thyroid cancer in U.S.
The University of Missouri Research Reactor (MURR) recently shipped its first batch of a medical isotope used to diagnose and treat thyroid cancer, making it the first domestic source of Iodine-131 (I-131) in 30 years. I-131 has only an eight-day half-life, making stockpiling impossible, and demand is expected to increase. Thyroid cancer is “the most rapidly increasing […]
ARTMS’ system may ease cost, shortage of valuable radioisotopes
ARTMS Products (Vancouver, B.C) has won the CE mark for its first-in-class, advanced technology Quantm irradiation system, designed to produce high-value medical imaging isotopes such as technetium-99m (Tc-99m) on medical cyclotrons. Tc-99m is given to nearly 50,000 Americans every day to diagnose cancer and heart disease. It is used in more than 80% of all nuclear […]
Medical tracer dev Shine Medical Tech raises $30m
Shine Medical Technologies raised $29.3 million in a new round of debt and option financing, according to an SEC filing posted this week. Shine Medical is a development-stage company working towards becoming a radioisotope manufacturer, according to the company’s website. The company touts that its proposed production technologies do not require a nuclear reactor, use […]
Medical isotope producer Shine Medical raises $27.2m
Shine Medical Technologies said last week in an SEC filing that it raised $27.2 million in a round of debt financing. Over 200 investors have contributed to the $29 million offering, which made its 1st sale on October 11, 2013. Monona, Wis.-based Shine Medical makes radioactive isotopes for medical diagnostic purposes such as detecting and treating cancer, according to the […]
NRC OKs Shine Medical isotope plant
Shine Medical Technologies said today it won clearance from the U.S. Nuclear Regulatory Commission to construct a medical isotope manufacturing facility. Shine Medical said the company is the only U.S. medical isotope producer to have reached this permission stage with the NRC since 1960 for the 57,000 square foot facility in Janesville, Wisc. “This is the […]
Medical isotope maker Shine Medical raises $11.5m
Shine Medical raised $11.5 million in a new round of debt financing, according to an SEC filing posted today. Monona, Wis.-based Shine Medical produces radioactive isotopes for medical applications such as detecting and treating heart disease and cancer, according to the company’s website. The company’s main product is Molybdenum -99, which is used in Technetium-99m […]
Imaging agent maker Shine Medical raises $11M | Wall Street Beat
Shine Medical closed an $11.4 million funding round for its method of generating a low-energy neutron source for medical imaging that uses a particle accelerator instead of a nuclear reactor.
MassDevice Network
@MassDevice
LinkedIn
YouTube